A WORLD OF GENETIC SOLUTIONS
Amplexa Genetics offers cutting-edge testing to help doctors diagnose and select appropriate treatment for their patients.
FERTILITY
Amplexa Genetics offers solutions to increase the chances of a good result with a variety of fertility treatments.
NON-INVASIVE
PGT-A
Increase the success rate for fertility clinics in IVF treatments
DONOR SCREENING PROGRAM
Our Whole Exome Screening is designed to uphold the utmost safety and compatibility for individuals and families planning their parenthood
NEUROLOGY
Firts step towards precision medicine is precision diagnosis
R&D
Expert guidance for transcriptomic discovery and assistance in setting up your experiment with professional precision.
SOLUTIONS FOR DOCTORS & PATIENTS
FERTILITY
Every fertility journey is different, and therefore the help that patients need is different. We want to help you offer the best treatment for your patients.
CLINICAL
One of the main challenges of current genetic medicine is supporting clinical diagnosis and providing preventive health care actions. Amplexa Genetics develops comprehensive clinical genetic tests.
NEUROLOGY
We offer the relevant test for patients suffering from epilepsy, intellectual disability, autism spectrum disorder with or without epilepsy.
SOLUTIONS FOR RESEARCH & TECHNICAL SERVICES
TECHNICAL SERVICES
We offer a variety of comprehensive, technical sequencing solutions, that combine science and information technology with our highly adaptable bioinformatics service.
RESEARCH & DEVELOPMENT
We are committed to advancing the field of genetic research by developing and refining sequencing-based methodologies.
BIOINFORMATICS
We can help you with everything from experimental design, the actual sequencing, data analysis, interpretation, as well as the production of publishable figures for the script or presentation.
AMPLEXA PUBLICATIONS
Find our publications here:
Applying cellular fixation and cell-type isolation for single-cell sequencing
Amplexa has supported Prof. Ditte C. Andersens-group in applying and validating a novel technique for cell isolation for single-cell sequencing that allows the samples to be stored at -80 degrees for a prolonged period before further single-cell library preparation.
Incorporating epilepsy genetics into clinical practice: a 360° evaluation
We evaluated a new epilepsy genetic diagnostic and counseling service covering a UK population of 3.5 million. We calculated diagnostic yield, estimated clinical impact, and surveyed referring clinicians and families. We costed alternative investigational pathways for neonatal onset epilepsy. Patients with epilepsy of unknown aetiology onset < 2 years; treatment resistant epilepsy; or familial epilepsy were referred for counseling and testing.
Importance of size of gene panels in diagnostics of children with epilepsy
Amplexa Genetics has in collaboration with three German laboratories; The Center for Human Genetics and Laboratory Diagnostics, CEGAT and Medical Genetics Center, has approved and published the article "Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size Matters".